MedPath

The double blinded, randomized placebo-controlled trial to evaluate the improvement effects of Oligonol ingestion on hidden obesity in healthy women.

Not Applicable
Conditions
Hidden obesity of healthy subjects
Registration Number
JPRN-UMIN000018905
Lead Sponsor
Wayo Women's University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1. Person having a disease 2. Person who takes medicine 3. Current smokers 4. Person having food allergy 5. Person who was diagnosed as an incompetent by doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Body compositions including body fat percentage, body weight and BMI: 0, 4, 8, 12 weeks
Secondary Outcome Measures
NameTimeMethod
Blood lipid- and glucose- related markers including triglyceride, cholesterol, glucose, HbA1c, adiponectine,leptine etc.
© Copyright 2025. All Rights Reserved by MedPath